BRIEF published on 03/27/2025 at 07:35, 1 year 7 months ago MaaT Pharma announces a capital increase of 13 million euros and 2024 annual results Financial Results Biotechnology Capital Increase MaaT013 AGvH
BRIEF published on 01/21/2025 at 18:05, 1 year 9 months ago Positive Results for MaaT033 Clinical Trial Biotechnology Security Oncology Clinical Trial MaaT033
PRESS RELEASE published on 12/10/2024 at 02:30, 1 year 10 months ago Inside Information / Other news releases
BRIEF published on 10/15/2024 at 07:35, 2 years ago MaaT Pharma Clinical Trial Recruitment Concluded Clinical Trial MaaT Pharma MaaT013 DSMB Notice AGvH Treatment
PRESS RELEASE published on 10/15/2024 at 07:30, 2 years ago Inside Information / Other news releases MaaT Pharma completes recruitment of its ARES Phase 3 Trial for MaaT013, a treatment for Acute Graft-versus-Host Disease, with topline results expected in January 2025 Clinical Trial MaaT Pharma MaaT013 ARES Phase 3 Trial Acute Graft-versus-Host Disease
BRIEF published on 09/04/2024 at 07:35, 2 years 1 month ago MaaT Pharma Announces Participation in Investor and Medical Conferences in September Investors Cancers Medical Conference MET Therapies Cell Transplantation
BRIEF published on 05/15/2024 at 07:35, 2 years 5 months ago MaaT Pharma successfully completes a fundraising of 19.2 million euros Biotechnology Fundraising Investment MaaT Pharma Clinical Tests
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 5 months ago Inside Information / News release on accounts, results MaaT Pharma announces successful completion of 19.2 million euros Global Offering with new shares, aims to fund R&D activities, Phase 3 trials, and broaden pipeline Biotechnology Fundraising Clinical Trials Global Offering MaaT Pharma
BRIEF published on 05/14/2024 at 19:39, 2 years 5 months ago MaaT Pharma Announces 18 Million Euro Global Offering and Strategic Developments Financial Strategy Phase 3 Trial Clinical-stage Biotechnology Global Offering Microbiome Ecosystem Therapies
PRESS RELEASE published on 05/14/2024 at 19:34, 2 years 5 months ago Inside Information / News release on accounts, results MaaT Pharma launches a global offering of approximately 18 million euros to fund R&D activities and expand shareholder base. Current shareholders commit to significant subscriptions Global Offering MaaT Pharma 18 Million Euros R&D Activities Shareholder Commitments
Published on 10/27/2026 at 17:47, 1 hour 23 minutes ago RecycLiCo and Alaska Energy Metals Collaborate to Test Proprietary Processing Methods on the Polymetallic Eureka Deposit, Nikolai Nickel Project, Alaska
Published on 10/27/2026 at 15:00, 4 hours 10 minutes ago PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, with 13.28 g/t Au, 5,204 g/t Ag and 5.4% Cu Over 1.0 m; and Completes the First Drill Hole at Portachuelos
Published on 10/27/2026 at 14:55, 4 hours 15 minutes ago Sun Valley Minerals Commences Trading on the TSX Venture Exchange; Launches Maiden Drill Program at Tarumán Main
Published on 10/27/2026 at 14:15, 4 hours 55 minutes ago As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides
Published on 10/27/2026 at 13:45, 5 hours 25 minutes ago Sekur Private Data Receives US$3.4 Million Per Year Quotation Request from African Government for 1,000 Command Bundle Licenses, 200 SekurOne Accounts and 200 Sekur Tactical Mobile Routers
Published on 10/27/2026 at 18:05, 1 hour 5 minutes ago BWH® Hotels Unveils Enterprise Transformation, Uniting Global Portfolio Under WorldHotels™
Published on 10/27/2026 at 17:45, 1 hour 25 minutes ago Broadpeak reports revenue for the first nine months of 2026.
Published on 10/27/2026 at 17:45, 1 hour 25 minutes ago Linedata Services: Nine-month 2026 revenue: €121.4m (+1.7% organic)
Published on 10/27/2026 at 17:15, 1 hour 55 minutes ago EQS-Adhoc: KAP AG ADJUSTS GUIDANCE FOR THE 2026 FINANCIAL YEAR
Published on 10/27/2026 at 15:49, 3 hours 20 minutes ago EQS-Adhoc: aconnic AG prolongs existing debt financing facility of EUR 23 million
Published on 10/27/2026 at 18:00, 1 hour 10 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 17:45, 1 hour 25 minutes ago First contract signed in Belgium for the construction of a 170 MW / 340 MWh battery energy storage system (BESS), in a temporary consortium with Eiffage Énergie Systèmes
Published on 10/27/2026 at 17:45, 1 hour 25 minutes ago Deezer delivers second consecutive quarter of revenue growth and upgrades its FY26 outlook
